Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

Bimolecular mechanisms are shown to produce reduced effects at high dose rates. Calculations using such mechanisms are shown to produce good agreement with data from devices affected by enhanced low ...